Related Experiment Video
Updated: Jun 16, 2026
07:00
Targeting of Deep Brain Structures with Microinjections for Delivery of Drugs, Viral Vectors, or Cell Transplants
Published on: December 1, 2010
Nanoparticulate devices for brain drug delivery.
Christian Celia1, Donato Cosco, Donatella Paolino
1Department of Pharmacobiological Sciences, Faculty of Pharmacy, University "Magna Graecia" of Catanzaro, Campus Universitario "Salvatore Venuta"-Building of BioSciences, Viale Europa, Catanzaro, Italy.
Medicinal Research Reviews
|February 18, 2010
Summary
Nanoparticulate colloidal devices offer a noninvasive method to deliver therapeutics across the blood-brain barrier (BBB). These systems improve drug accumulation in the central nervous system (CNS) by utilizing biocompatible materials and targeted delivery.
Area of Science:
- Neuroscience
- Nanotechnology
- Pharmacology
Background:
- The blood-brain barrier (BBB) restricts the passage of therapeutic agents into the central nervous system (CNS).
- Existing invasive methods for drug delivery to the brain carry risks and limitations.
- Developing noninvasive strategies is crucial for effective CNS drug delivery.
Purpose of the Study:
- To review strategies for designing nanoparticulate colloidal devices for CNS delivery.
- To highlight the potential of these nanoparticles as noninvasive brain drug delivery systems.
- To discuss the biological and clinical applications of nanoparticulate drug delivery in cerebral tissues.
Main Methods:
- Review of current literature on nanoparticulate systems for drug delivery.
- Analysis of strategies for designing nanoparticles for BBB penetration.
- Evaluation of targeting ligands and their role in specific brain tissue accumulation.
Main Results:
- Nanoparticulate colloidal devices provide a noninvasive approach to overcome the BBB.
- These systems utilize biocompatible and biodegradable materials, avoiding BBB disruption.
- Surface modification with ligands enables targeted delivery to specific CNS regions.
- Nanoparticles modulate drug properties, enhancing therapeutic efficacy.
Conclusions:
- Nanoparticulate colloidal devices represent a promising noninvasive strategy for brain drug delivery.
- Targeted nanoparticles offer potential for treating CNS pathologies with improved safety and efficacy.
- Further research into the design and application of these systems is warranted for clinical translation.
More Related Videos
Related Concept Videos
01:29Drug Delivery: Parenteral Route
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...